HANKS TB Diagnostics (Pty) Ltd
Health, Wellness & Fitness - , ,
HANKS TB Diagnostics (Pty) Ltd Employees
HANKS TB Diagnostics (Pty) Ltd Details
HANKS TB DIAGNOSTICS is a spin-off company with the mission of developing an accurate, affordable, fast and mobile diagnostic test to diagnose and monitor the active tuberculosis (TB) disease. The test is a molecular based platform technology that consists of a custom designed consumable kit and processing hardware that enables sample analysis. Currently the platform technology, with the inclusion of a live/dead differentiation step, can diagnose active TB from a crude processed sputum sample within 90 minutes at a cost of US$5 and a sensitivity of 82% and specificity of 90% in a cohort of first diagnosis and antibiotic treatment follow-ups. The test has the capability of drug resistance testing on the same sample collected for initial screening. This test algorithm has a large cost saving implication. Initial funding and support were received for the project from the South African Medical Research Council, the North-West University and The Innovation Hub's Biopark Incubator Programme. The main shareholders are the North-West University and BGM Pharmaceuticals with Nebraska University-Lincoln, USA as a collaborator. Our vision is to build the expertise and facilities for the manufacturing of molecular diagnostic hardware and kits locally.
HANKS TB Diagnostics (Pty) Ltd Technologies
Load Balancers
Varnish
CMS
Wix
Other
Shutterstock